Stifel Positive on Alto Neuroscience (ANRO): 'ALTO-203 Shows Interesting Signs of Activity But Not Thesis Impacting'
Tweet Send to a Friend
Stifel analyst Paul Matteis reiterated a Buy rating and $10.00 price target on Alto Neuroscience (NYSE: ANRO)The analyst comments "ANRO ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
